dsp 4 and 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one

dsp 4 has been researched along with 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blier, P; Cassano, T; Cuomo, V; Gobbi, G; Hen, R; Morgese, MG; Radja, F; Santarelli, L1

Other Studies

1 other study(ies) available for dsp 4 and 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one

ArticleYear
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2007, Volume: 17, Issue:5

    Topics: Action Potentials; Analgesics; Animals; Benzylamines; Drug Interactions; Indoles; Isoindoles; Locus Coeruleus; Male; Mice; Mice, Knockout; Neurokinin-1 Receptor Antagonists; Neurons; Neurotoxins; Norepinephrine; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Receptors, Neurokinin-1; Serotonin

2007